Interleukin 17 production among patients with American cutaneous leishmaniasis

Journal of Infectious Diseases

Volumn 200, Issue 1, 2009, Pages 75-78

  Bacallar, Olívia ^a   Faria, Daniela ^b   Nascimento, Márcia ^a   Cardoso, Thiago M ^a   Gollob, Kenneth J ^b   Dutra, Walderez O ^b   Scott, Phillip ^c   Carvalho, Edgar M ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17;

ARTICLE; BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; INFLAMMATION; LEISHMANIA BRAZILIENSIS; LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN LEISHMANIASIS;

AUTOIMMUNITY; HUMANS; INFLAMMATION; INTERLEUKIN-17; LEISHMANIASIS, MUCOCUTANEOUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; REFERENCE VALUES; TH1 CELLS;

EID: 67650682775     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/599380     Document Type: Article

References (15)

1. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003; 278:1910-4.
2. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004; 21:467-76.
3. Matsuzaki G, Umemura M. Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol 2007; 51:1139-47.
4. Hashimoto T, Akiyama K, Kobayashi N, Mori A. Comparison of IL17 production by helper T cells among atopic and nonatopic asthmatics and control subjects. Int Arch Allergy Immunol 2005; 137(Suppl 1): 51-4.
5. Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003; 14:155-74.
6. Bacellar O, Lessa H, Schriefer A, et al. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun 2002; 70: 6734-40.
7. Schriefer A, Wilson ME, Carvalho EM. Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis. Curr Opin Infect Dis 2008; 21:483-8.
8. Faria DR, Gollob KJ, Barbosa J Jr, et al. Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun 2005; 73:7853-9.
9. Bettelli E, Kom T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008; 453:1051-7.
10. Bottrel RL, Dutra WO, Martins FA, et al. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Infect Immun 2001; 69:3232-9.
11. Antonelli LR, Dutra WO, Almeida RP, Bacellar O, Carvalho EM, Gollob KJ. Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis. Immunol Lett 2005; 101:226-30.
12. Kelly MN, Kolls JK, Happel K, et al. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect Immun 2005; 73:617-21.
13. Vargas-Inchaustegui DA, Xin L, Soong L. Leishmania braziliensis infection induces dendritic cell activation, ISG15 transcription, and the generation of protective immune response. J Immunol 2008; 180: 7537-45.
14. Tuon FF, Gomes-Silva A, Da-Cruz AM, Duarte MI, Neto VA, Amato VS. Local immunological factors associated with recurrence of mucosal leishmaniasis. Clin Immunol 2008; 128:442-6.
15. Ribeiro de Jesus A, Luna T, Pacheco de Almeida R, Machado PR, Carvalho EM. Pentoxifylline down modulate in vitro T cell responses and attenuate pathology in Leishmania and HTLV-I infections. Int Immunopharmacol 2008; 8:1344-53.